| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |